Short answer
Pulmonx Corp (LUNG) filed an 8-K current report with the SEC on October 27, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Press release announces Pulmonx’s third-quarter 2026 financial results for the period ended September 30, 2026.
Pulmonx Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release announces Pulmonx’s third-quarter 2026 financial results for the period ended September 30, 2026
- Detailed results and management commentary are contained in Exhibit 99.1, “Pulmonx Reports Third Quarter 2026 Financial Results”
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $22.8M, up 6.2% year over year, reversing the nine-month decline of 2.5%
- U.S. revenue $14.9M, up 6.8%; international excluding China up 8.5% as Chinese commercial activity restarts
- Gross margin improved to 76% from 75%, while operating expenses fell 18% to $24.9M
- Net loss narrowed to $8.4M from $14.0M; Adjusted EBITDA loss improved 57% to $3.5M
- 2026 outlook: revenue $90M-$92M, gross margin approximately 77%, operating expenses $108M-$109M, cash decline approximately $22M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pulmonx Corp 8-K filings
Get the next LUNG 8-K as it lands
Follow LUNG for push alerts, or ask the research agent what this filing means.